Back to Journals » Open Access Journal of Clinical Trials » Volume 3

Original Research

Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)

       
Total article views   HTML views PDF downloads Totals
9,281 Dovepress* 9,281+ 2,285 11,566
Totals 9,281 2,285 11,566
*Since 6 February 2011
+Since July 2016

View citations on Google Scholar